1. Allgulander, C., Bandelow, B., Hollander, E., Montgomery, S. A., Nutt, D. J., Okasha, A., et al. (2003). WCA recommendations for the long-term treatment of generalized anxiety disorder. CNS Spectrums, 8(Suppl 1), 53–61.
2. American Psychiatric Association. (2002). Practice guideline for the treatment of patients with bipolar disorder. The American Journal of Psychiatry, 159(4 Suppl), 1–50.
3. Barker, M. J., Greenwood, K. M., Jackson, M., & Crowe, S. F. (2004a). Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs, 18, 37–48.
4. Barker, M. J., Greenwood, K. M., Jackson, M., & Crowe, S. F. (2004b). Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Archives of Clinical Neuropsychology, 19, 437–454.
5. Baxter Health Corporation. (2004). Lorazepam-lorazepam injection, solution (prescribing information). Deerfield, IL: Baxter Health Corporation.